May 2, 2021
MBChB, FRACS(urol)
Treatment of stone disease (flexible ureteroscopy + LASER, shock wave therapy, and percutaneous stone removal), treatment of benign prostatic disease, male incontinence, vasectomy, vasectomy reversal, circumcision, flexible cystoscopy, management of erectile dysfunction, prosthetic urology including penile implants and testicular prostheses.
da Vinci Xi Robotic Surgery
Mr Rod Studd is a specialist Urologist, a graduate of the University of Auckland and Fellow of the Royal Australasian College of Surgeons. His fellowship year (2005-2006) was spent working at The Prostate Centre, Vancouver General Hospital.
Rod practices general adult urology. His special interests lie in the management of prostate and bladder cancer. Rod is interested in risk assessment and diagnosis of prostate cancer. He utilises multi parametric prostate MRI which may reduce the requirement for biopsy in some men. He aims to minimize the discomfort and risk associated with prostate biopsy by offering trans-perineal techniques under general anaesthetic and trans-rectal biopsy under oral sedation and local anaesthetic.
Rod is a strong proponent of active surveillance for low risk prostate cancer, employing this in two thirds of men with low risk disease. He offers radical prostatectomy and prostate brachytherapy. He performs approximately 100 prostatectomies per year employing potency preserving techniques where appropriate. In advanced prostate cancer chemo-hormonal and radiation therapies are used, Rod liases closely with the medical oncology and radiation oncology teams. For invasive bladder cancer Rod performs cystectomy, extended pelvic lymph node dissection then neobladder or ileal conduit reconstruction.
Bruce Bennett says new technology that zeroes in on hard-to-target prostate cancer is a great advancement – he just wishes it had arrived earlier, and cheaper. After three biopsies, dating back to 2005, that missed his cancer, Bennett – a 65-year-old retired Wellington teacher – was tested earlier this year with new fusion biopsy technology, which found […]
Read moreAcurity Health Group and property partner Vital Healthcare Property Trust have confirmed base isolators will be employed in the $106 million re-development of Wellington’s Wakefield Hospital enabling it to remain operational after a major earthquake. Wellington City Council has granted a Resource Consent for the proposed new hospital. Enabling works are currently underway with construction expected […]
Read moreBase isolators will be part of Wakefield Hospital’s $106 million redevelopment to ensure it can keep operating following a major earthquake. Plans were announced in November to bowl most of Wellington’s largest private hospital, in Newtown, to make way for an upgrade which will give patients access to state-of-the art facilities. Acurity Health Group and property partner Vital […]
Read more